| human | Q5 |
| P496 | ORCID iD | 0000-0002-4751-1428 |
| P3829 | Publons author ID | 1703709 |
| P1053 | ResearcherID | K-9925-2015 |
| P1153 | Scopus author ID | 6602225280 |
| P69 | educated at | Faculty of Medicine of the University of São Paulo | Q8960737 |
| Faculdade de Ciências Médicas da Santa Casa de São Paulo | Q10279368 | ||
| P108 | employer | Fundação Pró-Sangue Hemocentro de São Paulo | Q30281644 |
| P735 | given name | Israel | Q19819746 |
| Israel | Q19819746 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q100388817 | A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings? |
| Q43255274 | Achievement of complete donor-type chimerism and remission with dasatinib in Philadelphia chromosome-positive ALL relapsing after allogeneic transplantation. |
| Q41470558 | BCR-ABL mutations in chronic myeloid leukemia treated with tyrosine kinase inhibitors and impact on survival |
| Q74392096 | CK-19 expression by RT-PCR in the peripheral blood of breast cancer patients correlates with response to chemotherapy |
| Q36364850 | Chronic myeloid leukemia treatment guidelines: Brazilian Association of Hematology, Hemotherapy and Cell Therapy. Brazilian Medical Association Guidelines Project - 2012. |
| Q91774643 | Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia |
| Q55363972 | Comparative study of different methodologies to detect the JAK2 V617F mutation in chronic BCR-ABL1 negative myeloproliferative neoplasms. |
| Q46846234 | Complete response to imatinib mesylate treatment in a 12-month-old patient with chronic myeloid leukemia |
| Q73488007 | Concomitant p53 mutation and MYCN amplification in neuroblastoma |
| Q42383073 | Current patient management of chronic myeloid leukemia in Latin America: a study by the Latin American Leukemia Net (LALNET). |
| Q61939618 | Dasatinib Overrides Imatinib Resistance Mediated by the F359I Residue Mutation in Two Patients with Chronic Myeloid Leukemia |
| Q45877535 | Deletion of the factor IX gene as a result of translocation t(X;1) in a girl affected by haemophilia B. |
| Q41501849 | Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance. |
| Q34272411 | Dynamic expression of desmin, α-SMA and TGF-β1 during hepatic fibrogenesis induced by selective bile duct ligation in young rats |
| Q34480479 | Early Detection of t(8;21) Chromosomal Translocations During Treatment of PML-RARA Positive Acute Promyelocytic Leukemia: A Case Study |
| Q54318898 | Effects of selective bile duct ligation on liver parenchyma in young animals: histologic and molecular evaluations. |
| Q34480473 | Efficacy and tolerability after unusually low doses of dasatinib in chronic myeloid leukemia patients intolerant to standard-dose dasatinib therapy. |
| Q46192237 | Emergence of abnormal clone with monsomy 7 in Philadelphia negative cells of CML patients treated with tyrosine kinase inhibitors |
| Q53114641 | Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scale. |
| Q50917057 | Evaluation of long-term outcomes, cytogenetic and molecular responses with imatinib mesylate in early and late chronic-phase chronic myeloid leukemia: a report from a single institute. |
| Q70822981 | Further evidence for the lack of correlation between the breakpoint site within M-BCR and CML prognosis and for the occasional involvement of p53 in transformation |
| Q50105278 | Growth hormone and insulin-like growth factor I axis and growth of children with different sickle cell anemia haplotypes |
| Q43633459 | Interferon-alpha therapy increases type I insulin-like growth factor receptors expression on lymphoid cells from patients with chronic myelogenous leukemia |
| Q38959390 | Investigation of human parvovirus B19 occurrence and genetic variability in different leukaemia entities |
| Q40599861 | Mdm2 mRNA expression in salivary gland tumour cell lines. |
| Q36081265 | Molecular and immunohistochemical analysis of P53 in phaeochromocytoma |
| Q54315749 | Molecular responses at 3 and 6 months after switching to a second-generation tyrosine kinase inhibitor are complementary and predictive of long-term outcomes in patients with chronic myeloid leukemia who fail imatinib. |
| Q77448858 | Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukemia |
| Q67658662 | N-myc oncogene expression and amplification in metastatic lesions of stage IV-S neuroblastoma |
| Q39414378 | Non-neoplastic bulky mediastinal mass presentation in an adolescent patient: a case report |
| Q44161665 | Pretherapeutic expression of the hOCT1 gene predicts a complete molecular response to imatinib mesylate in chronic-phase chronic myeloid leukemia. |
| Q51528452 | Prognostic impact of MYCN, DDX1, TrkA, and TrkC gene transcripts expression in neuroblastoma. |
| Q37085189 | Quantification of imatinib in human serum: validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays. |
| Q42933452 | Response to dasatinib in a patient with concomitant chronic myeloid leukemia and chronic lymphocytic leukemia. |
| Q91959736 | Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience |
| Q59447180 | Simultaneous Occurrence of Biphenotypic T Cell/Myeloid Lesions Involving t(12;13)(p13;q14) in a Pediatric Patient |
| Q81640211 | Simultaneous detection of JAK2 V617F mutation and Bcr-Abl translocation in a patient with chronic myelogenous leukemia |
| Q33708377 | Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy. |
| Q61939650 | The performance of semi-quantitative differential PCR is similar to that of real-time PCR for the detection of the MYCN gene in neuroblastomas |
| Q37389662 | Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study |
Search more.